Potential predictors and the frequency of development of thyroid and gastrointestinal neoplasms in the patients presenting with acromegaly
https://doi.org/10.14341/probl20156124-7
Abstract
This paper reports the results of research designed to study the possible predictors and the frequency of development of neoplasms in the thyroid gland and the gastrointestinal tract in the patients presenting with acromegaly. Special attention is given to the role of IGF-1 and IRI in the formation of tumours in the aforementioned organs and systems and the dependence of the frequency of their development on the patients’ age and (25)OH)D level. The detailed description of the features of the revealed thyroid and gastrointestinal neoplasms is presented.
About the Authors
O V Oleinik
Endocrinology Research Centre, Moscow
N N Molitvoslovova
Endocrinology Research Centre, Moscow
References
1. Baldvinsdottir T, Jonasson JG, Thorsson AV, et al. Epidemiology of pituitary tumorous in Iceland 1955-2007: a Nationwide study. // Endocrine Abstracts. 2008 ,16:315 (10th European Congress of Endocrinology, 3-7 May), Berlin, Germany.
2. Bates AS, Van’t Hoff W, Jones JM, Clayton RN. Does treatment of acromegaly affect life expectancy? // Metabolism. 1995;44:1-5. doi: 10.1016/0026-0495(95)90303-8.
3. Ayuk J, Clayton RN, Holder G, et al. Growth Hormone and Pituitary Radiotherapy, But Not Serum Insulin-Like Growth Factor-I Concentrations, Predict Excess Mortality in Patients with Acromegaly. // The Journal of Clinical Endocrinology & Metabolism. 2004;89(4):1613-1617. doi: 10.1210/jc.2003-031584.
4. Webb SM, Casanueva F, Wass JAH. Oncological Complications of Excess GH in Acromegaly. // Pituitary. 2002;5(1):21-25. doi: 10.1023/a:1022149300972.
5. dos Santos MCC, Nascimento GC, Nascimento AGC, et al. Thyroid cancer in patients with acromegaly: a case-control study. // Pituitary. 2012;16(1):109-114. doi: 10.1007/s11102-012-0383-y.
6. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. // Endocrine Reviews. 2004;25(1):102-152. doi: 10.1210/er.2002-0022.
7. Jenkins PJ, Besser M. CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem. // The Journal of Clinical Endocrinology & Metabolism. 2001;86(7):2935-2941. doi: 10.1210/jcem.86.7.7634.
8. Ogunkolade BW, Boucher BJ, Fairclough PD, et al. Expression of 25-hydroxyvitamin D-1-α-hydroxylase mRNA in individuals with colorectal cancer. // The Lancet. 2002;359(9320):1831-1832. doi: 10.1016/s0140-6736(02)08680-4.
Review
For citations:
Oleinik O.V., Molitvoslovova N.N. Potential predictors and the frequency of development of thyroid and gastrointestinal neoplasms in the patients presenting with acromegaly. Problems of Endocrinology. 2015;61(2):4-7. (In Russ.) https://doi.org/10.14341/probl20156124-7
Views:
328
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
